B

Biohaven Ltd
D

BHVN

40.580
USD
1.54
(3.94%)
مغلق
حجم التداول
40,717
الربح لكل سهم
-7
العائد الربحي
-
P/E
-4
حجم السوق
4,103,540,743
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.085
    (-0.48%)
    17.805 USD
    A
    AGIO
    0.790
    (2.37%)
    34.060 USD
    A
    ALKS
    0.140
    (0.47%)
    30.220 USD
    A
    ALLO
    0.08000
    (4.34%)
    1.92500 USD
    B
    BPMC
    -0.940
    (-0.84%)
    111.190 USD
    C
    CRSP
    2.740
    (6.61%)
    44.200 USD
    R
    RGNX
    0.28500
    (3.77%)
    7.85000 USD
    S
    SRPT
    -0.920
    (-0.79%)
    116.020 USD
    VRTX
    VRTX
    0.08
    (0.02%)
    428.09 USD
    المزيد
الأخبار
المقالات

العنوان: Biohaven Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.